Companies partner to perform trials of antimicrobial topical treatmentJanuary 9, 2019Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for new topical treatments based on Artilysin, a new antimicrobial platform technology.
SPONSORED CONTENTSupport patients' cognitive function and mobility.Cognitive and mobility decline are common issues facing aging pets, and new Hill's Prescription Diet Brain Care + j/d can help. + Learn More